Prelude Therapeutics, Inc. (PRLD)
1.89
+0.08
(+4.42%)
USD |
NASDAQ |
Jan 20, 12:32
Prelude Therapeutics Price: 1.89 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 102.42 |
| BioLife Solutions, Inc. | 24.66 |
| Protalix Biotherapeutics, Inc. | 2.035 |
| Aclaris Therapeutics, Inc. | 3.73 |
| Relay Therapeutics, Inc. | 7.50 |
Price Related Metrics
| PS Ratio | 12.75 |
| Price to Book Value | 2.030 |
| Earnings Yield | -85.36% |
| Market Cap | 118.82M |